Home Finance Mankind Pharma IPO Listing : Mankind Pharma’s listing will happen today, IPO...

Mankind Pharma IPO Listing : Mankind Pharma’s listing will happen today, IPO was subscribed more than 15 times

0
Mankind Pharma IPO Listing : Mankind Pharma's listing will happen today, IPO was subscribed more than 15 times
Mankind Pharma IPO Listing : Mankind Pharma's listing will happen today, IPO was subscribed more than 15 times

Mankind Pharma IPO Listing Mankind Pharma is the biggest IPO of 2023. The company has raised Rs 4326.35 crore from this IPO. Its listing can be done on both the main exchanges NSE and BSE by 11 am.

The listing of Mankind Pharma IPO can happen on Monday (May 8, 2023) at 11 am on both the stock exchanges NSE and BSE. The company’s IPO was open to public investors from April 25 to 27. The price band of the IPO was Rs 1026-1080.

Tremendous response was received in IPO

Mankind Pharma is the biggest IPO of the current financial year. The company has raised Rs 4326.35 crore through this IPO. This IPO got tremendous response from the investors. The IPO was subscribed more than 15 times. Out of this, the quota prescribed for Qualified Institutions was maximum subscribed 49.16 times, Non- Institutional Buyers’ quota 3.80 times and Retail Investors’ quota 0.92 times.

The Lead Managers of this IPO include Jefferies India Pvt, JP Morgan India Pvt Ltd, Kotak Mahindra Capital Company, Axis Capital and IIFL Securities.

Biggest IPO after Gland Pharma

Mankind Pharma’s IPO is the biggest public issue of this year so far. At the same time, this is the biggest IPO offered by any pharma after Gland Pharma. The size of the public issue of Gland Pharma was Rs 6,480 crore.

Business of Mankind Pharma

Mankind Pharma is the fourth largest pharma company in the country by sales. The business of the company is spread all over India. It has 25 manufacturing plants. The company has a full team of 600 scientists and research and development centers. The company’s profit in the nine months April – December 2022 has been Rs 996.4 crore. During this period, the company’s income has increased by 10 percent to Rs 6697 crore.

Exit mobile version